Oragenics, Inc. to Present at The Centurion One Capital 2nd Annual Bahamas Summit
18 Octobre 2024 - 2:30PM
Oragenics Inc. (NYSE American: OGEN), a company focused on
developing new treatments for brain-related health conditions,
announced it will be presenting at the Centurion One Capital 2nd
Annual Bahamas Summit to be held at the Rosewood Baha Mar Hotel on
October 22-23, 2024, in Nassau, Bahamas. Michael Redmond, President
of Oragenics, will participate in a corporate presentation and
Q&A session on October 22, 2024 at 1:20 pm ET.
Details for the presentation are as
follows:Date: Tuesday, October 22, 2024Time: 1:20 p.m.
EDTPresenter: Michael Redmond, President of OragenicsRegister for
the event by clicking here.
About Oragenics:
Oragenics is a development-stage biotechnology company focused
on nasal delivery of pharmaceutical medications in neurology and
fighting infectious diseases, including drug candidates for
treating mild traumatic brain injury (mTBI), also known as
concussion, and for treating Niemann Pick Disease Type C (NPC), as
well as proprietary powder formulation and an intranasal delivery
device. For more information, please
visit www.oragenics.com.
Investor Relations:Rich CockrellCG
Capital404-736-3838ogen@cg.capital
Oragenics (AMEX:OGEN)
Graphique Historique de l'Action
De Nov 2024 à Déc 2024
Oragenics (AMEX:OGEN)
Graphique Historique de l'Action
De Déc 2023 à Déc 2024
